| SMITH & NEPHEW |
| Großbritannien |
| Gesundheit |
| GB0009223206 / 502816 |
| NPW1 (Frankfurt) |
| FRA:NPW1, ETR:NPW1, NPW1:GR |
| FTSE100 |
| https://www.smith-nephew... |
|
Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three..
>Volltext.. |
| 11034.64 Mio. EUR |
| 13673.46 Mio. EUR |
| 5538.1 Mio. EUR |
| 1471.73 Mio. EUR |
| 558.24 Mio. EUR |
| 0.65 EUR |
| 3364.43 Mio. EUR |
| 670.22 Mio. EUR |
| 1166.48 Mio. EUR |
| 0.37 |
| 1.77% |
| 24.24% |
| 0.35 EUR |
| 2.68% |
| 2.63% |
| 01.10.26 - 0.138606€ 26.03.26 - 0.20894699€ >weitere anzeigen... |
| - |
| SMITH & NEPHEW, SMITHNEPHEW, SMITH NEPHEW, SMITH&NEPHEW |
| 04.11.26 |
|
||||
|